Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: AMERISOURCEBERGEN DRUG CORP
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-05-16 to 2024-05-17
Current total value of award: $834.47
Description: 4564626988!QUILLIVANT XR ORAL SUSP 180ML 5MG/ML